Pemivibart
Generic Name: pemivibart
Dosage form: INJECTION. Active ingredients: PEMIVIBART (125 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION. Active ingredients: PEMIVIBART (125 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection.
Related Medications
Oxytetracycline Hcl
oxytetracycline hcl
Dosage form: POWDER. Active ingredients: OXYTETRACYCLINE HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.
Carya Laciniosa
carya laciniosa
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: CARYA LACINIOSA POLLEN (20000 [PNU]/mL). Category: BLA.
Donanemab-azbt
donanemab-azbt
11 DESCRIPTION Donanemab-azbt is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against insoluble N-truncated pyroglutamate amyloid beta, and is expressed in a Chinese hamster ovary cell line. Donanemab-azbt has an approximate molecular weight of 145 kDa. KISUNLA (donanemab-azbt) injection is a sterile, preservative-free, clear to opalescent, colorless to slightly yellow to slightly brown solution for intravenous infusion after dilution.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.